ABCELLERA BIOLOGICS (8QQ) — Cash Flow Reinvestment Rate
ABCELLERA BIOLOGICS (8QQ) has a Cash Flow Reinvestment Rate of 0.39x as of June 2026, reinvesting €10.01 Million (capex €2.13 Million plus investments €7.88 Million) from operating cash flow of €25.92 Million. See ABCELLERA BIOLOGICS free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ABCELLERA BIOLOGICS Cash Flow Reinvestment Rate (2021–2022)
Historical reinvestment intensity for ABCELLERA BIOLOGICS across 2 annual periods. For the full cash flow conversion analysis, see ABCELLERA BIOLOGICS cash conversion from operations.
Annual Cash Flow Reinvestment Rate for ABCELLERA BIOLOGICS (2021–2022)
Year-by-year capital reinvestment analysis for ABCELLERA BIOLOGICS. See financial agility of ABCELLERA BIOLOGICS to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.24x | €343.38 Million | €277.36 Million | €72.66 Million | ▼ -6.3% |
| 2021 | 1.32x | €323.09 Million | €244.58 Million | €58.45 Million | — |